2021

MPs and MEPs Call for TRIPS Waiver

Over 100 MEPs call for a TRIPS Waiver

Access to Medicines in Europe

2020

There is no UHC without Universal Medicines Coverage

HAI’s Great Health Hack Delivers Great Ideas for Access to Meds

Europe Faces a Critical Time of Key Medicine Shortages Amidst a Pandemic

What do the next five years have in store for the European Medicines Agency?

Dutch institutions failing to register results of clinical trials

COVID-19 risks turning back the clock on years of essential development work

Reflections on the World Health Assembly

EU Must Not Miss its Chance on WHO Technology Pool

TRIPS-flexibilities in Health Crises and Beyond

In defence of WHO

HAI Follows Dutch Government Advice in Response to COVID-19

HAI Recognised for Commitment to Gender Equality

2019

A Momentous Week for Access to Medicines

Welcome to the new look website!

Dr Marg Ewen Receives the Helen Clark-JoPPP Award

2018

Staff Spotlight: Jaume Vidal

How WHO’s Internship Policy Became More Inclusive

A Week of Promise for Access to Medicines

What Role Can Civil Society Play in the European Regulatory Process?

Open Science for Health: Shaping the New Framework Programme

2017

EU-Mercosur Trade Agreement: A bad deal for transparency, policy coherence and access to medicines

Facing a Global Threat – Roadmap to Combat Antimicrobial Resistance and the Bumps Along the Way

The Forgotten Victims of Snakebite

Giving Snakebite Victims a Voice

Small country, big thinkers: Why it’s only natural for the Netherlands to take on a pioneering role in snakebite advocacy

European Commission Appoints Health Action International to HTA Network Stakeholder Pool

2016

Clinical Trial Data Transparency on Trial – EMA Under Pressure From Pharma Lawsuit